Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.

ABSTRACT:

Background

Human papillomavirus (HPV) vaccination was introduced in 2006 for females and in 2011 for males.

Objective

To estimate vaccine impact and effectiveness against quadrivalent HPV vaccine (4vHPV)-type prevalent infection among sexually experienced U.S. females and vaccine effectiveness for sexually experienced U.S. males.

Design

NHANES (National Health and Nutrition Examination Survey) conducted in 2003 to 2006 (prevaccine era) and in 2007 to 2010, 2011 to 2014, and 2015 to 2018 (vaccine eras).

Setting

Nationally representative U.S. surveys.

Participants

Sexually experienced participants aged 14 to 24 years.

Intervention

U.S. HPV vaccination program.

Measurements

Participant-collected cervicovaginal and penile specimens were tested

SUBMITTER: Rosenblum HG 

PROVIDER: S-EPMC11614147 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature